LPCN
Price:
$3.1
Market Cap:
$16.63M
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis; LPCN 1111, an oral prodrug of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical trial ...[Read more]
Industry
Biotechnology
IPO Date
2013-10-22
Stock Exchange
NASDAQ
Ticker
LPCN
According to Lipocine Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.04. This represents a change of 274.42% compared to the average of -0.81 of the last 4 quarters.
The mean historical PE Ratio of Lipocine Inc. over the last ten years is 300.26. The current -3.04 PE Ratio has changed -201.25% with respect to the historical average. Over the past ten years (40 quarters), LPCN's PE Ratio was at its highest in in the December 2024 quarter at 3.65. The PE Ratio was at its lowest in in the December 2015 quarter at -12.74.
Average
300.26
Median
-3.21
Minimum
-87.70
Maximum
3.12K
Discovering the peaks and valleys of Lipocine Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.35%
Maximum Annual PE Ratio = 3.12K
Minimum Annual Increase = -347053.37%
Minimum Annual PE Ratio = -87.70
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 3.12K | -347053.37% |
| 2023 | -0.90 | -71.39% |
| 2022 | -3.14 | -96.42% |
| 2021 | -87.70 | 2.35% |
| 2020 | -3.58 | 366.82% |
| 2019 | -0.77 | -67.56% |
| 2018 | -2.36 | -27.85% |
| 2017 | -3.28 | -7.41% |
| 2016 | -3.54 | -69.62% |
| 2015 | -11.65 | 254.33% |
The current PE Ratio of Lipocine Inc. (LPCN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.04K
5-year avg
604.84
10-year avg
300.26
Lipocine Inc.’s PE Ratio is less than OSR Holdings, Inc. (-0.91), less than Adaptimmune Therapeutics plc (-0.08), less than Adlai Nortye Ltd. (-0.25), less than BioLineRx Ltd. (-1.69), less than GeoVax Labs, Inc. (-0.31), less than Edesa Biotech, Inc. (-2.01), less than ProMIS Neurosciences, Inc. (-0.36), less than Ernexa Therapeutics Inc. (-0.59), less than Lunai Bioworks Inc. (-0.12), less than Moleculin Biotech, Inc. (-0.28),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.91 | $17.76M | |
| -0.08 | $75.16M | |
| -0.25 | $37.48M | |
| -1.69 | $14.17M | |
| -0.31 | $9.73M | |
| -2.01 | $11.89M | |
| -0.36 | $9.98M | |
| -0.59 | $10.28M | |
| -0.12 | $23.14M | |
| -0.28 | $9.32M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lipocine Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lipocine Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Lipocine Inc.'s PE Ratio?
How is the PE Ratio calculated for Lipocine Inc. (LPCN)?
What is the highest PE Ratio for Lipocine Inc. (LPCN)?
What is the 3-year average PE Ratio for Lipocine Inc. (LPCN)?
What is the 5-year average PE Ratio for Lipocine Inc. (LPCN)?
How does the current PE Ratio for Lipocine Inc. (LPCN) compare to its historical average?